Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.25 Billion CNY | -29.32% |
| 2022 | 1.77 Billion CNY | 48.43% |
| 2021 | 1.19 Billion CNY | -9.69% |
| 2020 | 1.32 Billion CNY | 24.36% |
| 2019 | 1.06 Billion CNY | 3.22% |
| 2018 | 1.03 Billion CNY | 46.43% |
| 2017 | 705.86 Million CNY | -34.28% |
| 2016 | 1.07 Billion CNY | 55.38% |
| 2015 | 691.25 Million CNY | -16.51% |
| 2014 | 827.95 Million CNY | 62.87% |
| 2013 | 508.36 Million CNY | 35.92% |
| 2012 | 374.02 Million CNY | 20.45% |
| 2011 | 310.51 Million CNY | 0.33% |
| 2010 | 309.49 Million CNY | 108.3% |
| 2009 | 148.58 Million CNY | 1.98% |
| 2008 | 145.7 Million CNY | 32.48% |
| 2007 | 109.98 Million CNY | 110.74% |
| 2006 | 52.18 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.34 Billion CNY | 7.21% |
| 2024 Q2 | 1.67 Billion CNY | 24.51% |
| 2024 Q3 | 1.58 Billion CNY | -5.37% |
| 2023 Q4 | 1.25 Billion CNY | -15.31% |
| 2023 Q3 | 1.48 Billion CNY | -12.77% |
| 2023 Q2 | 1.7 Billion CNY | 14.64% |
| 2023 FY | 1.25 Billion CNY | -29.32% |
| 2023 Q1 | 1.48 Billion CNY | -16.55% |
| 2022 Q1 | 1.64 Billion CNY | 37.12% |
| 2022 FY | 1.77 Billion CNY | 48.43% |
| 2022 Q4 | 1.77 Billion CNY | 5.19% |
| 2022 Q3 | 1.69 Billion CNY | -8.18% |
| 2022 Q2 | 1.84 Billion CNY | 12.08% |
| 2021 Q1 | 1.2 Billion CNY | -9.51% |
| 2021 FY | 1.19 Billion CNY | -9.69% |
| 2021 Q4 | 1.19 Billion CNY | -6.79% |
| 2021 Q3 | 1.28 Billion CNY | 6.44% |
| 2021 Q2 | 1.2 Billion CNY | 0.59% |
| 2020 Q4 | 1.32 Billion CNY | 4.62% |
| 2020 Q1 | 1.34 Billion CNY | 25.87% |
| 2020 FY | 1.32 Billion CNY | 24.36% |
| 2020 Q3 | 1.26 Billion CNY | -13.61% |
| 2020 Q2 | 1.46 Billion CNY | 9.32% |
| 2019 Q2 | 1.01 Billion CNY | 11.02% |
| 2019 Q1 | 911.89 Million CNY | -11.77% |
| 2019 FY | 1.06 Billion CNY | 3.22% |
| 2019 Q4 | 1.06 Billion CNY | -4.29% |
| 2019 Q3 | 1.11 Billion CNY | 10.12% |
| 2018 Q4 | 1.03 Billion CNY | -2.47% |
| 2018 Q3 | 1.05 Billion CNY | 92.25% |
| 2018 FY | 1.03 Billion CNY | 46.43% |
| 2018 Q2 | 551.22 Million CNY | -8.47% |
| 2018 Q1 | 602.25 Million CNY | -14.68% |
| 2017 Q3 | 709.61 Million CNY | 7.85% |
| 2017 Q2 | 657.94 Million CNY | -34.92% |
| 2017 FY | 705.86 Million CNY | -34.28% |
| 2017 Q4 | 705.86 Million CNY | -0.53% |
| 2017 Q1 | 1.01 Billion CNY | -5.87% |
| 2016 FY | 1.07 Billion CNY | 55.38% |
| 2016 Q4 | 1.07 Billion CNY | 0.18% |
| 2016 Q1 | 699.87 Million CNY | 1.25% |
| 2016 Q3 | 1.07 Billion CNY | 4.04% |
| 2016 Q2 | 1.03 Billion CNY | 47.24% |
| 2015 Q4 | 691.25 Million CNY | -20.26% |
| 2015 FY | 691.25 Million CNY | -16.51% |
| 2015 Q3 | 866.86 Million CNY | 46.79% |
| 2015 Q1 | 609.73 Million CNY | -26.36% |
| 2015 Q2 | 590.56 Million CNY | -3.14% |
| 2014 Q4 | 827.95 Million CNY | 101.98% |
| 2014 Q1 | 464.43 Million CNY | -8.64% |
| 2014 Q3 | 409.92 Million CNY | -41.86% |
| 2014 FY | 827.95 Million CNY | 62.87% |
| 2014 Q2 | 705.07 Million CNY | 51.81% |
| 2013 Q1 | 357 Million CNY | -4.55% |
| 2013 FY | 508.36 Million CNY | 35.92% |
| 2013 Q4 | 508.36 Million CNY | 18.64% |
| 2013 Q3 | 428.48 Million CNY | 36.13% |
| 2013 Q2 | 314.76 Million CNY | -11.83% |
| 2012 Q4 | 374.02 Million CNY | -5.24% |
| 2012 FY | 374.02 Million CNY | 20.45% |
| 2012 Q1 | 347.75 Million CNY | 11.99% |
| 2012 Q2 | 395.77 Million CNY | 13.81% |
| 2012 Q3 | 394.71 Million CNY | -0.27% |
| 2011 Q1 | 302 Million CNY | -2.42% |
| 2011 Q3 | 364.35 Million CNY | -4.98% |
| 2011 FY | 310.51 Million CNY | 0.33% |
| 2011 Q4 | 310.51 Million CNY | -14.78% |
| 2011 Q2 | 383.45 Million CNY | 26.97% |
| 2010 Q2 | 295.73 Million CNY | 61.64% |
| 2010 Q1 | 182.95 Million CNY | 23.13% |
| 2010 Q4 | 309.49 Million CNY | -15.76% |
| 2010 FY | 309.49 Million CNY | 108.3% |
| 2010 Q3 | 367.41 Million CNY | 24.24% |
| 2009 Q3 | 157.82 Million CNY | -15.26% |
| 2009 FY | 148.58 Million CNY | 1.98% |
| 2009 Q2 | 186.25 Million CNY | 0.0% |
| 2009 Q4 | 148.58 Million CNY | -5.85% |
| 2008 Q4 | 145.7 Million CNY | 0.0% |
| 2008 FY | 145.7 Million CNY | 32.48% |
| 2007 FY | 109.98 Million CNY | 110.74% |
| 2006 FY | 52.18 Million CNY | 0.0% |